Menu
Search
|

Menu

Close
X

Bayer AG BAYGN.DE (Xetra)

78.07 EUR
-- (--)
As of Oct 15
chart
Previous Close 78.07
Open --
Volume --
3m Avg Volume 3,809,727
Today’s High --
Today’s Low --
52 Week High 118.04
52 Week Low 69.40
Shares Outstanding (mil) 826.95
Market Capitalization (mil) 96,918.28
Forward P/E 22.18
Dividend (Yield %) 2.70 ( 2.30 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.81 Mean rating from 26 analysts

KEY STATS

Revenue (mm, EUR)
FY18
18,619
FY17
35,015
FY16
40,768
FY15
46,085
EPS (EUR)
FY18
3.076
FY17
3.439
FY16
4.791
FY15
4.790
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
22.18
32.75
Price to Sales (TTM)
vs sector
2.00
5.74
Price to Book (MRQ)
vs sector
2.97
5.00
Price to Cash Flow (TTM)
vs sector
12.04
23.28
Total Debt to Equity (MRQ)
vs sector
58.82
16.89
LT Debt to Equity (MRQ)
vs sector
43.39
12.55
Return on Investment (TTM)
vs sector
8.69
14.60
Return on Equity (TTM)
vs sector
16.39
16.33

EXECUTIVE LEADERSHIP

Werner Wenning
Independent Chairman of the Supervisory Board, Since 2012
Salary: €360,000.00
Bonus: --
Werner Baumann
Chairman of the Management Board, Chief Executive Officer, Since 2016
Salary: €1,487,000.00
Bonus: €49,000.00
Oliver Zuehlke
Independent Vice Chairman of the Supervisory Board, Employee Representative, Since 2015
Salary: €240,000.00
Bonus: --
Hartmut Klusik
Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director, Since 2016
Salary: €756,000.00
Bonus: €40,000.00
Jennifer Brendelto
Vice President - Communications of the Consumer Health Division, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Kaiser-Wilhelm-Allee 1
LEVERKUSEN     51373

Phone: +49214.301

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

SPONSORED STORIES